|
|
 Previous Article | Table of Contents | Next Article 
Cytotoxic T-Lymphocyte-Defined Human Minor Histocompatibility
Antigens With a Restricted Tissue Distribution
Edus H. Warren,
Philip D. Greenberg, and
Stanley R. Riddell
From the Fred Hutchinson Cancer Research Center, Seattle, WA; and the
University of Washington, Seattle, WA.
Cytotoxic T lymphocytes (CTL) specific for human minor
histocompatibility (H) antigens can be isolated from the blood of major histocompatibility complex (MHC)-matched allogeneic bone marrow transplant (BMT) recipients and may play a prominent role in the graft-versus-host (GVH) and graft-versus-leukemia (GVL) reactions (Tsoi
et al, J Immunol 125:2258, 1980; Tsoi et al, Transplant Proc 15:1484, 1983; Goulmy et al, Nature 302:159, 1983;
Irle et al, Transplantation 40:329, 1985; and Niederwieser et
al, Blood 81:2200, 1993). The identification of
minor H antigens that are expressed in hematopoietic cells, including
leukemic cells, but not in fibroblasts and other tissue types has
suggested that such tissue-restricted antigens could potentially serve
as targets for T-cell immunotherapy to enhance GVL activity without
inducing GVH disease (de Bueger et al, J Immunol 149:1788,
1992; van der Harst et al, Blood 83:1060, 1994; and Dolstra et
al, J Immunol 158:560, 1997). To explore the feasibility of
this strategy, donor CD3+CD8+ CTL clones
specific for recipient minor H antigens were isolated and characterized
from allogeneic BMT recipients. CTL clones were obtained from the
majority of donor/recipient pairs. Seventeen distinct minor H antigens
distinguishable by their MHC-restricting allele, population frequency,
and/or distribution of tissue expression were defined by 56 CD3+CD8+ CTL clones isolated from these
patients. The MHC-restricting alleles for these CTL clones included
HLA-A2 and HLA-B7, which had previously been shown to present minor H
antigens to CTL, as well as HLA-A3, -A11, -B8, -B53, and -Cw7, which
had not previously been described to present minor H antigens to CTL.
Estimated phenotype frequencies for these 17 distinct minor H antigens
range from 0.17 to 0.92. In vitro cytotoxicity assays using
hematopoietic cells and fibroblasts as target cells showed that 5 of
the 17 minor H antigens were expressed in both hematopoietic cells and fibroblasts. However, 12 were presented for CTL recognition only by
hematopoietic cells and not by dermal fibroblasts derived from the same
donors. These results significantly extend the spectrum of CTL-defined
human minor H antigens that could potentially serve as target antigens
for cellular immunotherapy to promote GVL activity after allogeneic
BMT.
Blood, Vol. 91 No. 6 (March 15), 1998:
pp. 2197-2207
© 1998 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
H.-J. Kolb
Graft-versus-leukemia effects of transplantation and donor lymphocytes
Blood,
December 1, 2008;
112(12):
4371 - 4383.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. M. Spaapen, H. M. Lokhorst, K. van den Oudenalder, B. E. Otterud, H. Dolstra, M. F. Leppert, M. C. Minnema, A. C. Bloem, and T. Mutis
Toward targeting B cell cancers with CD4+ CTLs: identification of a CD19-encoded minor histocompatibility antigen using a novel genome-wide analysis
J. Exp. Med.,
November 24, 2008;
205(12):
2863 - 2872.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. S. Tykodi, N. Fujii, N. Vigneron, S. M. Lu, J. K. Mito, M. X. Miranda, J. Chou, L. N. Voong, J. A. Thompson, B. M. Sandmaier, et al.
C19orf48 Encodes a Minor Histocompatibility Antigen Recognized by CD8+ Cytotoxic T Cells from Renal Cell Carcinoma Patients
Clin. Cancer Res.,
August 15, 2008;
14(16):
5260 - 5269.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. V. Rosinski, N. Fujii, J. K. Mito, K. K. W. Koo, S. M. Xuereb, O. Sala-Torra, J. S. Gibbs, J. P. Radich, Y. Akatsuka, B. J. Van den Eynde, et al.
DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cells
Blood,
May 1, 2008;
111(9):
4817 - 4826.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Rezvani, A. S. M. Yong, B. N. Savani, S. Mielke, K. Keyvanfar, E. Gostick, D. A. Price, D. C. Douek, and A. J. Barrett
Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia
Blood,
September 15, 2007;
110(6):
1924 - 1932.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. C. Wehler, M. Nonn, B. Brandt, C. M. Britten, M. Grone, M. Todorova, I. Link, S. A. Khan, R. G. Meyer, C. Huber, et al.
Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines
Blood,
January 1, 2007;
109(1):
365 - 373.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. H. Warren, N. J. Vigneron, M. A. Gavin, P. G. Coulie, V. Stroobant, A. Dalet, S. S. Tykodi, S. M. Xuereb, J. K. Mito, S. R. Riddell, et al.
An antigen produced by splicing of noncontiguous peptides in the reverse order.
Science,
September 8, 2006;
313(5792):
1444 - 1447.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. G. Brickner, A. M. Evans, J. K. Mito, S. M. Xuereb, X. Feng, T. Nishida, L. Fairfull, R. E. Ferrell, K. A. Foon, D. F. Hunt, et al.
The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL
Blood,
May 1, 2006;
107(9):
3779 - 3786.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. B. Miklos, H. T. Kim, K. H. Miller, L. Guo, E. Zorn, S. J. Lee, E. P. Hochberg, C. J. Wu, E. P. Alyea, C. Cutler, et al.
Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission
Blood,
April 1, 2005;
105(7):
2973 - 2978.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. S. Tykodi, E. H. Warren, J. A. Thompson, S. R. Riddell, R. W. Childs, B. E. Otterud, M. F. Leppert, R. Storb, and B. M. Sandmaier
Allogeneic Hematopoietic Cell Transplantation for Metastatic Renal Cell Carcinoma after Nonmyeloablative Conditioning: Toxicity, Clinical Response, and Immunological Response to Minor Histocompatibility Antigens
Clin. Cancer Res.,
December 1, 2004;
10(23):
7799 - 7811.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Takahashi, J. P. McCoy Jr, C. Carvallo, C. Rivera, T. Igarashi, R. Srinivasan, N. S. Young, and R. W. Childs
In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation
Blood,
February 15, 2004;
103(4):
1383 - 1390.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H.-J. Kolb, C. Schmid, A. J. Barrett, and D. J. Schendel
Graft-versus-leukemia reactions in allogeneic chimeras
Blood,
February 1, 2004;
103(3):
767 - 776.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Weber, C. Lange, W. Gunther, M. Franz, E. Kremmer, and H.-J. Kolb
Minor Histocompatibility Antigens on Canine Hemopoietic Progenitor Cells
J. Immunol.,
June 15, 2003;
170(12):
5861 - 5868.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Akatsuka, T. Nishida, E. Kondo, M. Miyazaki, H. Taji, H. Iida, K. Tsujimura, M. Yazaki, T. Naoe, Y. Morishima, et al.
Identification of a Polymorphic Gene, BCL2A1, Encoding Two Novel Hematopoietic Lineage-specific Minor Histocompatibility Antigens
J. Exp. Med.,
June 2, 2003;
197(11):
1489 - 1500.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Murata, E. H. Warren, and S. R. Riddell
A Human Minor Histocompatibility Antigen Resulting from Differential Expression due to a Gene Deletion
J. Exp. Med.,
May 19, 2003;
197(10):
1279 - 1289.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. J. N. Cooper, M. S. Topp, L. M. Serrano, S. Gonzalez, W.-C. Chang, A. Naranjo, C. Wright, L. Popplewell, A. Raubitschek, S. J. Forman, et al.
T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect
Blood,
February 15, 2003;
101(4):
1637 - 1644.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. J. Amrolia, S. D. Reid, L. Gao, B. Schultheis, G. Dotti, M. K. Brenner, J. V. Melo, J. M. Goldman, and H. J. Stauss
Allorestricted cytotoxic T cells specific for human CD45 show potent antileukemic activity
Blood,
February 1, 2003;
101(3):
1007 - 1014.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. E. Heslop, F. K. Stevenson, and J. J. Molldrem
Immunotherapy of Hematologic Malignancy
Hematology,
January 1, 2003;
2003(1):
331 - 349.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. F. Storb, G. Lucarelli, P. A. McSweeney, and R. W. Childs
Hematopoietic Cell Transplantation for Benign Hematological Disorders and Solid Tumors
Hematology,
January 1, 2003;
2003(1):
372 - 397.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. P. Hochberg, D. B. Miklos, D. Neuberg, D. A. Eichner, S. F. McLaughlin, A. Mattes-Ritz, E. P. Alyea, J. H. Antin, R. J. Soiffer, and J. Ritz
A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantation
Blood,
January 1, 2003;
101(1):
363 - 369.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Zorn, K. S. Wang, E. P. Hochberg, C. Canning, E. P. Alyea, R. J. Soiffer, and J. Ritz
Infusion of CD4+ Donor Lymphocytes Induces the Expansion of CD8+ Donor T Cells with Cytolytic Activity Directed against Recipient Hematopoietic Cells
Clin. Cancer Res.,
July 1, 2002;
8(7):
2052 - 2060.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. A. Nijmeijer, R. Willemze, and J. H. F. Falkenburg
An animal model for human cellular immunotherapy: specific eradication of human acute lymphoblastic leukemia by cytotoxic T lymphocytes in NOD/scid mice
Blood,
June 28, 2002;
100(2):
654 - 660.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. H. J. Vogt, J. W. van den Muijsenberg, E. Goulmy, E. Spierings, P. Kluck, M. G. Kester, R. A. van Soest, J. W. Drijfhout, R. Willemze, and J. H. F. Falkenburg
The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease
Blood,
April 15, 2002;
99(8):
3027 - 3032.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Hoelzer, N. Gokbuget, O. Ottmann, C.-H. Pui, M. V. Relling, F. R. Appelbaum, J. J.M. van Dongen, and T. Szczepanski
Acute Lymphoblastic Leukemia
Hematology,
January 1, 2002;
2002(1):
162 - 192.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. McSweeney, D. Niederwieser, J. A. Shizuru, B. M. Sandmaier, A. J. Molina, D. G. Maloney, T. R. Chauncey, T. A. Gooley, U. Hegenbart, R. A. Nash, et al.
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects
Blood,
June 1, 2001;
97(11):
3390 - 3400.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. J. Dengler, D. R. Johnson, and J. S. Pober
Human Vascular Endothelial Cells Stimulate a Lower Frequency of Alloreactive CD8+ Pre-CTL and Induce Less Clonal Expansion than Matching B Lymphoblastoid Cells: Development of a Novel Limiting Dilution Analysis Method Based on CFSE Labeling of Lymphocytes
J. Immunol.,
March 15, 2001;
166(6):
3846 - 3854.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. G. Brickner, E. H. Warren, J. A. Caldwell, Y. Akatsuka, T. N. Golovina, A. L. Zarling, J. Shabanowitz, L. C. Eisenlohr, D. F. Hunt, V. H. Engelhard, et al.
The Immunogenicity of a New Human Minor Histocompatibility Antigen Results from Differential Antigen Processing
J. Exp. Med.,
January 8, 2001;
193(2):
195 - 206.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. R. Appelbaum, J. M. Rowe, J. Radich, and J. E. Dick
Acute Myeloid Leukemia
Hematology,
January 1, 2001;
2001(1):
62 - 86.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. F. Storb, R. Champlin, S. R. Riddell, M. Murata, S. Bryant, and E. H. Warren
Non-Myeloablative Transplants for Malignant Disease
Hematology,
January 1, 2001;
2001(1):
375 - 391.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. S. Serody, S. E. Burkett, A. Panoskaltsis-Mortari, J. Ng-Cashin, E. McMahon, G. K. Matsushima, S. A. Lira, D. N. Cook, and B. R. Blazar
T-lymphocyte production of macrophage inflammatory protein-1alpha is critical to the recruitment of CD8+ T cells to the liver, lung, and spleen during graft-versus-host disease
Blood,
November 1, 2000;
96(9):
2973 - 2980.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. H. J. Vogt, E. Goulmy, F. M. Kloosterboer, E. Blokland, R. A. de Paus, R. Willemze, and J. H. F. Falkenburg
UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition
Blood,
November 1, 2000;
96(9):
3126 - 3132.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. J. Dengler and J. S. Pober
Human Vascular Endothelial Cells Stimulate Memory But Not Naive CD8+ T Cells to Differentiate into CTL Retaining an Early Activation Phenotype
J. Immunol.,
May 15, 2000;
164(10):
5146 - 5155.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Borrello, E. M. Sotomayor, F.-M. Rattis, S. K. Cooke, L. Gu, and H. I. Levitsky
Sustaining the graft-versus-tumor effect through posttransplant immunization with granulocyte-macrophage colony-stimulating factor (GM-CSF)-producing tumor vaccines
Blood,
May 15, 2000;
95(10):
3011 - 3019.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. E. Georges, R. Storb, J. D. Thompson, C. Yu, T. Gooley, B. Bruno, and R. A. Nash
Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation
Blood,
May 15, 2000;
95(10):
3262 - 3269.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. H. Warren, M. A. Gavin, E. Simpson, P. Chandler, D. C. Page, C. Disteche, K. A. Stankey, P. D. Greenberg, and S. R. Riddell
The Human UTY Gene Encodes a Novel HLA-B8-Restricted H-Y Antigen
J. Immunol.,
March 1, 2000;
164(5):
2807 - 2814.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Brenner, C. Rossig, U. Sili, J. W. Young, and E. Goulmy
Transfusion Medicine: New Clinical Applications of Cellular Immunotherapy
Hematology,
January 1, 2000;
2000(1):
356 - 375.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J. Wu, A. Chillemi, E. P. Alyea, E. Orsini, D. Neuberg, R. J. Soiffer, and J. Ritz
Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism
Blood,
January 1, 2000;
95(1):
352 - 359.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Bonnet, E. H. Warren, P. D. Greenberg, J. E. Dick, and S. R. Riddell
CD8+ minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells
PNAS,
July 20, 1999;
96(15):
8639 - 8644.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. W. Childs, E. Clave, J. Tisdale, M. Plante, N. Hensel, and J. Barrett
Successful Treatment of Metastatic Renal Cell Carcinoma With a Nonmyeloablative Allogeneic Peripheral-Blood Progenitor-Cell Transplant: Evidence for a Graft-Versus-Tumor Effect
J. Clin. Oncol.,
July 1, 1999;
17(7):
2044 - 2044.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. C. Biedermann and J. S. Pober
Human Vascular Endothelial Cells Favor Clonal Expansion of Unusual Alloreactive CTL
J. Immunol.,
June 15, 1999;
162(12):
7022 - 7030.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Dolstra, H. Fredrix, F. Maas, P. G. Coulie, F. Brasseur, E. Mensink, G. J. Adema, T. M. de Witte, C. G. Figdor, and E. van de Wiel-van Kemenade
A Human Minor Histocompatibility Antigen Specific for B Cell Acute Lymphoblastic Leukemia
J. Exp. Med.,
January 18, 1999;
189(2):
301 - 308.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
